Treating Queer and Transgendered patients – Nigel Tonto Ching

Generated with Avocode.Group 238Path 825Path 826Path 827Path 828Path 829Path 830Path 831Path 832Path 833Path 834Path 835Path 836Path 837Path 838Path 839Path 840Path 841Path 842Path 843Path 844Path 845Path 846Path 847Path 848Path 849Path 850Path 851Path 852Path 853Path 854Path 855Path 856Path 857Path 858Path 859Path 860Path 861Path 862Path 863Path 864Path 865Path 866Path 867Path 868Path 869Path 870Path 871Path 872Path 873Path 874Path 875Path 876Path 877Path 878Path 879Path 880Path 881Path 882Path 883Path 884Path 885Path 886Path 887Path 888Path 889Path 890Path 891Path 892Path 893Path 894Path 895Path 896Path 897
Giving the practitioner a greater understanding of the issues involved when treating queer and transgendered patients

Lecture from ICCM#2018

Queer and transgendered (TG) individuals are a small, but growing group within the community at large and thereby also as potential patients. This group is increasingly visible, not because there are more people who are becoming or recognising that they are transgendered or queer, but because it is less stigmatised than as little as 10-15 years ago.
When treating transgendered (TG) and queer patients there are several factors that need to be taken into consideration. In this lecture I will try to summarise some of the issues that it is useful to be aware of, both with regards to potential aetiology as well as understanding a patients background and situation

עשית כבר לייק לעמוד הפייסבוק שלנו?

Leave a Reply

Your email address will not be published. Required fields are marked *

סדנא עם Dr. Yu Guo Jun בישראל ​

שלושה ימים של צמחי מרפא סיניים